• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, January 31, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Ipca Laboratories Rating ‘Buy’; margins were higher than estimated

by The Outlooker Web Desk
November 15, 2020
in Business
0
Ipca Laboratories Rating ‘Buy’; margins were higher than estimated
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Excluding anti-malarial drugs, domestic business was up 6% y-o-y, as Pain & Analgesics, which accounts for more than half the domestic revenue, was up 10% y-o-y.

Ipca reported a 7% miss in revenue, driven by a dip in India anti-malarial season and UK payment issues. Adjusting for these one-off effects, revenue was in line. At 25%, margins came in better than expected, driven by all-round cost savings. Management has guided for improvement in India business growth for H2 and 25-27% margins for remaining FY21/22/23 on the back of sustainable cost savings. We upgrade FY21/22e EPS by 17/10%. Buy India business recovers, (ex-malarial) sales up 6% y-o-y: Total domestic revenue was flat y-o-y, largely due to base erosion in anti-malarial drugs that registered sales of Rs 560 m vs Rs 950 m last year.

Excluding anti-malarial drugs, domestic business was up 6% y-o-y, as Pain & Analgesics, which accounts for more than half the domestic revenue, was up 10% y-o-y. Management guided for 10-11% domestic revenue growth for the next two quarters and we factor this in our model.

API strength to continue: Ipca’s export API business revenue has grown by 43% over H1FY21/H2FY20. Q1FY21 reflected HCQS sales but it has normalised in Q2. The company has guided to 18-20% growth in API business for rest of FY21.

Better visibility on margins, in line with peers: Several pharma companies have guided that margin improvement as seen in H1FY21 is sustainable. In case of Ipca, this is driven by operating leverage as well as reduced marketing spends.

We retain Buy; value company at 29.8x FY22e EPS with a PT of Rs 2,757.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Retired Delhi School Principal Arrested For Looting Job Aspirants: Police

Case Of Murder Filed Against Odisha Collector, Office Staff

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak
National

Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak

January 31, 2023
Nitish Kumar’s Sulking Aide Upendra Kushwaha Recalls A 1994 Challenge To Lalu Yadav
National

Nitish Kumar’s Sulking Aide Upendra Kushwaha Recalls A 1994 Challenge To Lalu Yadav

January 31, 2023
Virat Kohli, Anushka Sharma’s Spiritual Break In Rishikesh Ahead of Australia Test Series
National

Virat Kohli, Anushka Sharma’s Spiritual Break In Rishikesh Ahead of Australia Test Series

January 31, 2023
Seven Killed, Several Others Injured In Jeep-Trailer Truck Collision In Rajasthan
National

More Than 100 Students Fall Ill Due To Suspected Food Poisoning In Andhra Pradesh

January 30, 2023

Connect with us

No Result
View All Result

Archives

  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Padma Awardee Author Sudha Murty’s 4-Point Advice To Son-In-Law Rishi Sunak
  • Nitish Kumar’s Sulking Aide Upendra Kushwaha Recalls A 1994 Challenge To Lalu Yadav
  • Virat Kohli, Anushka Sharma’s Spiritual Break In Rishikesh Ahead of Australia Test Series

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.